Proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials

Objectives: To examine the proportion of the total treatment effect that is attributable to contextual effects in randomised controlled trials (RCTs) of treatments for fibromyalgia. Methods: A systematic literature search was undertaken in Medline, Web of Science, EMBASE, Cumulative Index to Nursin...

Full description

Bibliographic Details
Main Authors: Whiteside, Nicola, Sarmanova, Aliya, Chen, Xi, Zou, Kun
Format: Article
Published: Springer 2017
Subjects:
Online Access:https://eprints.nottingham.ac.uk/48663/
_version_ 1848797818379042816
author Whiteside, Nicola
Sarmanova, Aliya
Chen, Xi
Zou, Kun
author_facet Whiteside, Nicola
Sarmanova, Aliya
Chen, Xi
Zou, Kun
author_sort Whiteside, Nicola
building Nottingham Research Data Repository
collection Online Access
description Objectives: To examine the proportion of the total treatment effect that is attributable to contextual effects in randomised controlled trials (RCTs) of treatments for fibromyalgia. Methods: A systematic literature search was undertaken in Medline, Web of Science, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Allied and Complementary Medicine in September 2015. The proportion of contextualeffect (PCE) was calculated by dividing the improvement in the placebo arm by the improvement in the treatment arm. The measure was log-transformed for each trial and the random effects model was used to pool data. The primary outcome was pain. Secondary outcomes were fibromyalgia impact questionnaire (FIQ) total and fatigue. Heterogeneity was quantified using I2. Publication bias was assessed using a funnel plot and Egger's test. Subgroup analysis was undertaken to explore heterogeneity and potential determinants of the PCE. Results: 51 eligible trials (9599 participants) were identified. The PCE was 0.60 (95% CI0·56 to 0·64) for pain, 0·57 (95% CI 0·53 to 0·61) for FIQ total, and 0·63 (95% CI 0·59 to 0·68) for fatigue. The I2 was 99.4% for pain, 99.2% for FIQ total, and 97.6% for fatigue. Conclusion: More than half of the treatment effect in fibromyalgia RCTs results from non-specific contextual factors. Reporting the total treatment effect and the proportion of contextual effect in trials may help to better translate research evidence into clinical practice.
first_indexed 2025-11-14T20:09:55Z
format Article
id nottingham-48663
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:09:55Z
publishDate 2017
publisher Springer
recordtype eprints
repository_type Digital Repository
spelling nottingham-486632020-05-04T19:23:22Z https://eprints.nottingham.ac.uk/48663/ Proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials Whiteside, Nicola Sarmanova, Aliya Chen, Xi Zou, Kun Objectives: To examine the proportion of the total treatment effect that is attributable to contextual effects in randomised controlled trials (RCTs) of treatments for fibromyalgia. Methods: A systematic literature search was undertaken in Medline, Web of Science, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Allied and Complementary Medicine in September 2015. The proportion of contextualeffect (PCE) was calculated by dividing the improvement in the placebo arm by the improvement in the treatment arm. The measure was log-transformed for each trial and the random effects model was used to pool data. The primary outcome was pain. Secondary outcomes were fibromyalgia impact questionnaire (FIQ) total and fatigue. Heterogeneity was quantified using I2. Publication bias was assessed using a funnel plot and Egger's test. Subgroup analysis was undertaken to explore heterogeneity and potential determinants of the PCE. Results: 51 eligible trials (9599 participants) were identified. The PCE was 0.60 (95% CI0·56 to 0·64) for pain, 0·57 (95% CI 0·53 to 0·61) for FIQ total, and 0·63 (95% CI 0·59 to 0·68) for fatigue. The I2 was 99.4% for pain, 99.2% for FIQ total, and 97.6% for fatigue. Conclusion: More than half of the treatment effect in fibromyalgia RCTs results from non-specific contextual factors. Reporting the total treatment effect and the proportion of contextual effect in trials may help to better translate research evidence into clinical practice. Springer 2017-12-20 Article PeerReviewed Whiteside, Nicola, Sarmanova, Aliya, Chen, Xi and Zou, Kun (2017) Proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials. Clinical Rheumatology . ISSN 1434-9949 fibromyalgia meta-analysis contextual effect systematic review https://link.springer.com/article/10.1007%2Fs10067-017-3948-3 doi:10.1007/s10067-017-3948-3 doi:10.1007/s10067-017-3948-3
spellingShingle fibromyalgia
meta-analysis
contextual effect
systematic review
Whiteside, Nicola
Sarmanova, Aliya
Chen, Xi
Zou, Kun
Proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials
title Proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials
title_full Proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials
title_fullStr Proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials
title_full_unstemmed Proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials
title_short Proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials
title_sort proportion of contextual effects in the treatment of fibromyalgia - a meta-analysis of randomised controlled trials
topic fibromyalgia
meta-analysis
contextual effect
systematic review
url https://eprints.nottingham.ac.uk/48663/
https://eprints.nottingham.ac.uk/48663/
https://eprints.nottingham.ac.uk/48663/